Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.200
-0.390 (-8.50%)
At close: Mar 6, 2026, 4:00 PM EST
4.160
-0.040 (-0.95%)
After-hours: Mar 6, 2026, 4:04 PM EST
Camp4 Therapeutics Employees
Camp4 Therapeutics had 55 employees as of December 31, 2024. The number of employees decreased by 9 or -14.06% compared to the previous year.
Employees
55
Change (1Y)
-9
Growth (1Y)
-14.06%
Revenue / Employee
$63,600
Profits / Employee
-$1,461,873
Market Cap
217.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 55 | -9 | -14.06% |
| Dec 31, 2023 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 220 |
| Protalix BioTherapeutics | 213 |
| Voyager Therapeutics | 172 |
| Cibus | 159 |
| MediWound | 111 |
| Alector | 103 |
| Keros Therapeutics | 78 |
| Sol-Gel Technologies | 34 |
CAMP News
- 19 hours ago - CAMP4 to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 1 day ago - CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 14 days ago - CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Camp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 2 months ago - CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries - GlobeNewsWire
- 3 months ago - CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire